Alentic Microscience Inc.
Alentic Microscience Inc. is dedicated to revolutionizing diagnostic technology by providing rapid, portable blood testing solutions. Their innovative lensless microscopy technology allows for comprehensive blood analysis using just a drop of blood, making healthcare more accessible and affordable.
Industries
N/A
Nr. of Employees
small (1-50)
Alentic Microscience Inc.
1344 Summer Street, Halifax, NS, Canada, B3H 0A8
Patents
Products
Pocket-sized lensless imaging diagnostic device
A compact diagnostic instrument that uses lensless multispectral imaging and on-device analysis to perform complete blood counts and other blood-based assays from a single drop of blood with minimal sample preparation.
Pocket-sized lensless imaging diagnostic device
A compact diagnostic instrument that uses lensless multispectral imaging and on-device analysis to perform complete blood counts and other blood-based assays from a single drop of blood with minimal sample preparation.
Services
Collaborative development and prototyping of diagnostic assays and ruggedized instrument variants for remote or space environments under government and agency contracts.
Collaborative development and prototyping of diagnostic assays and ruggedized instrument variants for remote or space environments under government and agency contracts.
Expertise Areas
- Point-of-care diagnostics
- Clinical hematology and CBC assay development
- Imaging-based cytometry
- Embedded AI and on-device neural-network inference
Key Technologies
- Lensless microscopy
- Multispectral imaging
- Digital image sensor-based imaging
- Microspectrophotometry
News & Updates
BARDA is continuing its partnership to develop fieldable diagnostics to rapidly identify individual exposures to ionizing radiation following a nuclear or radiological incident.
The Canadian Space Agency (CSA) and Impact Canada have selected the 20 semi-finalists for the Deep Space Healthcare Challenge, a competition to develop innovative healthcare technologies for people living in remote communities now, and crews on long-duration space missions in the future.
Advanced computer programs that use machine learning are transforming the way medical research is done in Nova Scotia and around the world.
The Atlantic Canada Opportunities Agency is providing a $2.99 million loan to Alentic Microscience Inc., which has devised a pocket-sized diagnostic device that can generate test results in under five minutes, from any location, using only a drop of blood from a pinprick.
BARDA is continuing its partnership to develop fieldable diagnostics to rapidly identify individual exposures to ionizing radiation following a nuclear or radiological incident.
The Canadian Space Agency (CSA) and Impact Canada have selected the 20 semi-finalists for the Deep Space Healthcare Challenge, a competition to develop innovative healthcare technologies for people living in remote communities now, and crews on long-duration space missions in the future.
Advanced computer programs that use machine learning are transforming the way medical research is done in Nova Scotia and around the world.
The Atlantic Canada Opportunities Agency is providing a $2.99 million loan to Alentic Microscience Inc., which has devised a pocket-sized diagnostic device that can generate test results in under five minutes, from any location, using only a drop of blood from a pinprick.